Cargando…
Developing Vaccines to Combat Pandemic Influenza
Influenza vaccine manufacturers require antigenically relevant vaccine viruses that have good manufacturing properties and are safe to use. In developing pandemic vaccine viruses, reverse genetics has been employed as a rational approach that can also be used effectively to attenuate the highly viru...
Autores principales: | Robertson, James S., Engelhardt, Othmar G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185603/ https://www.ncbi.nlm.nih.gov/pubmed/21994647 http://dx.doi.org/10.3390/v2020532 |
Ejemplares similares
-
Many ways to make an influenza virus – review of influenza virus reverse genetics methods
por: Engelhardt, Othmar G.
Publicado: (2012) -
A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine
por: Harvey, Ruth, et al.
Publicado: (2014) -
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
por: Tung Yep, Andrew, et al.
Publicado: (2021) -
Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14
por: Johnson, Rachel E., et al.
Publicado: (2012) -
Correction: Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14
por: Johnson, Rachel E., et al.
Publicado: (2012)